跳至主要内容
临床试验/NCT06222619
NCT06222619已完成不适用

Effect of Portal Vein Embolization on Surgical Outcomes and Long-term Survival in Patients With Perihilar Cholangiocarcinoma

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 136 人开始时间: 2020年1月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
136
试验地点
1
主要终点
Overall survival

研究概览

简要总结

Portal vein embolization is often recommended to reduce the risk of postoperative liver failure and mortality. In this retrospective cohort study, researchers investigated the effect of portal vein embolization in patients with resectable perihilar cholangiocarcinoma bismuth type III and IV.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • patients with Bismuth type III or IV stricture on radiological examination, including computed tomography (CT) or magnetic resonance cholangiography
  • patients with perihilar cholangiocarcinoma histologically confirmed by surgical resection or forceps biopsy/brush cytology under endoscopic retrograde cholangiopancreatography or through the percutaneous transhepatic biliary drainage tract.

排除标准

  • patients with unresectable perihilar cholangiocarcinoma
  • patients who refused treatment
  • patients with other concomitant malignancies.

结局指标

主要结局

Overall survival

时间窗: The time from diagnosis until the date of death or last date of follow-up or end of study up to 24 months

Overall survival of each group (A-C).

次要结局

  • Recurrence free survival(The time from surgical resection until the date of recurrence or death or last date of follow-up or end of study up to 24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sang Hyub Lee

Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验